Tenet Healthcare Corporation (THC)

Tenet Healthcare Stock Forecast

Stock Price Forecast

The 17 analysts with 12-month price forecasts for Tenet Healthcare stock have an average target of 136.12, with a low estimate of 81 and a high estimate of 175. The average target predicts a decrease of -10.23% from the current stock price of 151.63.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$81	$136.12	$140	$175
Change	-46.58%	-10.23%	-7.67%	+15.41%

Analyst Ratings

The average analyst rating for THC stock from 17 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Feb '24	Mar '24	Apr '24	May '24	Jun '24	Jul '24
Strong Buy	9	8	8	9	8	8
Buy	6	8	8	8	8	8
Hold	1	1	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	16	17	17	18	17	17

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Jason Cassorla Citigroup	Citigroup	Strong Buy Maintains $139 → $171	Strong Buy	Maintains	$139 → $171	+12.77%	Jul 25, 2024
John Ransom Raymond James	Raymond James	Strong Buy Maintains $130 → $175	Strong Buy	Maintains	$130 → $175	+15.41%	Jul 25, 2024
David Macdonald Truist Securities	Truist Securities	Strong Buy Reiterates $155 → $170	Strong Buy	Reiterates	$155 → $170	+12.12%	Jul 25, 2024
Sarah James Cantor Fitzgerald	Cantor Fitzgerald	Buy Maintains $112 → $168	Buy	Maintains	$112 → $168	+10.80%	Jul 25, 2024
David Macdonald Truist Securities	Truist Securities	Strong Buy Maintains $130 → $155	Strong Buy	Maintains	$130 → $155	+2.22%	Jul 15, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

20.66B

Increased by 0.47%

from 20.56B

Revenue Next Year

21.49B

Increased by 4.00%

from 20.66B

EPS This Year

8.95

Increased by 56.78%

from 5.71

EPS Next Year

9.35

Increased by 4.44%

from 8.95

Year	2019	2020	2021	2022	2023	2024	2025	2026	2027	2028
Revenue	18.48B	18.52B	19.68B	19.37B	20.56B	20.66B	21.49B	22.56B	23.54B	24.49B
Revenue Growth	0.91%	0.23%	6.23%	-1.57%	6.18%	0.47%	4.00%	5.00%	4.32%	4.04%
EPS	-2.08	3.75	8.42	3.79	5.71	8.95	9.35	10.48	11.90	12.50
EPS Growth	-	-	124.53%	-54.99%	50.66%	56.78%	4.44%	12.06%	13.56%	5.09%
Forward PE	-	-	-	-	-	16.94	16.22	14.47	12.74	12.13
No. Analysts	-	-	-	-	-	21	20	13	2	2

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2024	2025	2026	2027	2028
High	22.5B	23.3B	24.6B	24.5B	25.5B
Avg	20.7B	21.5B	22.6B	23.5B	24.5B
Low	19.8B	20.6B	21.4B	22.8B	23.8B

Revenue Growth

Revenue Growth	2024	2025	2026	2027	2028
High	9.6%	12.8%	14.3%	8.4%	8.2%
Avg	0.5%	4.0%	5.0%	4.3%	4.0%
Low	-3.8%	-0.5%	-0.6%	1.2%	0.9%

EPS Forecast

EPS	2024	2025	2026	2027	2028
High	10.57	12.32	13.48	12.37	13.00
Avg	8.95	9.35	10.48	11.90	12.50
Low	8.07	7.95	8.82	11.54	12.13

EPS Growth

EPS Growth	2024	2025	2026	2027	2028
High	85.1%	37.6%	44.2%	18.1%	9.3%
Avg	56.8%	4.4%	12.1%	13.6%	5.1%
Low	41.3%	-11.2%	-5.7%	10.2%	2.0%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.